Neuroprotective Effect of Vitamin E Supplementation
In Patients Treated with Cisplatin Chemotherapy
 (PubMed, Journal of Clinical Oncology, 3/1/03)

Researchers at Regina Elena National Cancer Institute in Rome, Italy, studied 47 patients who were receiving cisplatin chemotherapy. Some of the subjects were given 300 mg of Vitamin E prior to each treatment, continuing for a period of 3 months following treatment suspension. The scientists found that the incidence and severity of peripheral neurotoxicity were significantly lower for the participants receiving the Vitamin E.